Davis's Drug Guide
[Display All Sections]

lyme disease vaccine (recombinant OspA)


IM: (Adults 15–70 yr): 30 mcg/0.5-mL dose given at 0, 1, and 12 mo. Administration of 2nd and 3rd doses should take place several weeks prior to the beginning of the B. burgdorferi transmission season in a particular area.

lyme disease vaccine (recombinant OspA) is a sample topic found in
Nursing Central.

To find other Nursing Central topics
please login or purchase a subscription.

Content Manager